However, as surgical interventions such as hepatic lobectomy and bile duct resection are highly invasive, the number of eligible cases is limited, and when surgical resection is not a viable option, the management of obstructive jaundice and cholangitis due to mucin production is often a significant challenge. This evidence concerns the gene MUC5AC and cholangitis.